Product Information

BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Padagis US LLC, priced at $8.4146 per ML under NDC 00574401215. Its NADAC has been published 153 times since Dec 13, 2023.

FDA first approved this application on Jul 28, 2023.

BRINZOLAMIDE 1% EYE DROPS

brinzolamide
$8.4146per ML

Strength

10 mg/mL

Manufacturer

Padagis US LLC

NDC

00574401215

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA211914

FDA Approved

7/28/2023

On Market Since

10/10/2023

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 153 times since Dec 13, 2023, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4146 per ML
All-time high$17.2178 (Mar 12, 2025)
All-time low$7.2636 (May 22, 2024)
52-week high$14.3013
52-week low$8.4146
Median price$12.2762
Average price$12.0622
Largest weekly change-39.2% (May 22, 2024)
Weeks tracked153
Tracking sinceDec 13, 2023

Price History

1W

0.0%

1M

-11.2%

3M

-18.1%

6M

-16.5%

1Y

-32.3%

3Y

N/A

5Y

N/A

All

-48.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Padagis US LLC, is $8.4146 per ML (NDC 00574401215), effective Nov 11, 2026.

How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 48.9%. It has been tracked across 153 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?

Since Dec 13, 2023, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $7.2636 (May 22, 2024) to a high of $17.2178 (Mar 12, 2025), with a median of $12.2762 per ML.

Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $7.9504 per ML — about 6% below BRINZOLAMIDE 1% EYE DROPS.

Who manufactures BRINZOLAMIDE 1% EYE DROPS?

BRINZOLAMIDE 1% EYE DROPS (NDC 00574401215) is labeled by Padagis US LLC, and CMS classifies it as a generic product.